Suppr超能文献

急性大血管闭塞性缺血性卒中的再通治疗:我们现在在哪里,下一步该做什么?

Recanalization Therapy for Acute Ischemic Stroke with Large Vessel Occlusion: Where We Are and What Comes Next?

机构信息

Department of Neurology, University of California, Irvine, 200 S. Manchester Ave., Suite 206, CA, 92868, Orange, USA.

出版信息

Transl Stroke Res. 2021 Jun;12(3):369-381. doi: 10.1007/s12975-020-00879-w. Epub 2021 Jan 6.

Abstract

In the past 5 years, the success of multiple randomized controlled trials of recanalization therapy with endovascular thrombectomy has transformed the treatment of acute ischemic stroke with large vessel occlusion. The evidence from these trials has now established endovascular thrombectomy as standard of care. This review will discuss the chronological evolution of large vessel occlusion treatment from early medical therapy with tissue plasminogen activator to the latest mechanical thrombectomy. Additionally, it will highlight the potential areas in endovascular thrombectomy for acute ischemic stroke open to exploration and further progress in the next decade.

摘要

在过去的 5 年中,多次血管内血栓切除术再通治疗的随机对照试验取得了成功,改变了大血管闭塞性急性缺血性脑卒中的治疗方法。这些试验的证据现在已经确立了血管内血栓切除术作为标准治疗。本综述将讨论从早期使用组织型纤溶酶原激活物的药物治疗到大血管闭塞治疗的时间顺序演变,到最新的机械血栓切除术。此外,它还将突出强调血管内血栓切除术在急性缺血性脑卒中治疗方面的潜在探索领域,并展望未来十年的进一步进展。

相似文献

2
Endovascular vs medical management of acute ischemic stroke.急性缺血性卒中的血管内治疗与药物治疗
Neurology. 2015 Dec 1;85(22):1980-90. doi: 10.1212/WNL.0000000000002176. Epub 2015 Nov 4.

引用本文的文献

2
Neurovascular Complications of Acute Aortic Syndrome.急性主动脉综合征的神经血管并发症
J Stroke. 2025 Jan;27(1):19-29. doi: 10.5853/jos.2024.02915. Epub 2025 Jan 31.
10
Stem Cell- and Cell-Based Therapies for Ischemic Stroke.用于缺血性中风的干细胞和基于细胞的疗法。
Bioengineering (Basel). 2022 Nov 20;9(11):717. doi: 10.3390/bioengineering9110717.

本文引用的文献

9
Opening the time window.打开时间窗口。
J Cereb Blood Flow Metab. 2019 Dec;39(12):2539-2540. doi: 10.1177/0271678X19882782. Epub 2019 Oct 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验